Clinical Trial Update: Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the CRE8 stent for de novo coronary artery lesions, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CRE8 stent

Snippet

Sponsor: CID S.p.A. | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN